Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Hbv Tdf'

Hbv Tdf published presentations and documents on DocSlides.

IAS – USA Fall New York Course: Case Discussion

IAS – USA Fall New York Course: Case Discussion

  • jalin
  • 61 Slides

Luke . Jerram. Disclosures: Educational grant supp...

Background Long-term use of antiretroviral therapy (

Background Long-term use of antiretroviral therapy (

  • jaena
  • 1 Slides

cART. ) in aged HIV-1-infected individuals could e...

Switching the NRTI Backbone to Tenofovir DF-Emtricitabine

Switching the NRTI Backbone to Tenofovir DF-Emtricitabine

  • reese
  • 5 Slides

TOTEM. Switching the NRTI Backbone to Tenofovir DF...

Dolutegravir-Lamivudine (

Dolutegravir-Lamivudine (

  • audrey
  • 43 Slides

Dovato. ). Last Updated: November 28, 2022. Prepar...

Optimizing HIV treatment

Optimizing HIV treatment

  • anderson
  • 26 Slides

Professor Francois Venter. Ezintsha, University of...

Challenging Cases in Antiretroviral Therapy and Panel Discussion

Challenging Cases in Antiretroviral Therapy and Panel Discussion

  • gagnon
  • 73 Slides

Paul E. Sax, MD. Professor of Medicine. Harvard Me...

Tryptophane Metabolites Predict Neurocognitive Impairment and Side Effects during Efavirenz

Tryptophane Metabolites Predict Neurocognitive Impairment and Side Effects during Efavirenz

  • piper
  • 1 Slides

A nested analysis of the Swear randomized multicen...

CROI 2015: Treatment and Cure Highlights

CROI 2015: Treatment and Cure Highlights

  • unita
  • 23 Slides

Shireesha Dhanireddy. Robert Harrington. March 17,...

Any PRM at baseline Yes No

Any PRM at baseline Yes No

  • lucy
  • 1 Slides

39. 129. 100 . (91, 100). 98 . (95, 100). NRTI PRM...

Introduction Characteristics, Treatment Patterns,

Introduction Characteristics, Treatment Patterns,

  • cappi
  • 1 Slides

and . Virologic. Outcomes . for Treatment-experie...

DTG/3TC 1st line (GEMINI)

DTG/3TC 1st line (GEMINI)

  • oryan
  • 37 Slides

ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...

Susan P. Buchbinder, MD Director, Bridge HIV

Susan P. Buchbinder, MD Director, Bridge HIV

  • harmony
  • 48 Slides

San . Francisco Department . of Public Health. Cli...

Novel Antiretroviral Studies and Strategies

Novel Antiretroviral Studies and Strategies

  • danya
  • 14 Slides

Bob Harrington, MD. University of Washington . Pre...

Stephanie Cox Gilead Sciences

Stephanie Cox Gilead Sciences

  • emery
  • 6 Slides

Foster City, CA. ULTRASENSITIVE HIV-1 DRUG RESISTA...

PrEP scale up and STI management in Brazil

PrEP scale up and STI management in Brazil

  • winnie
  • 26 Slides

Valdilea. G. . Veloso. @. Valdilea. Share your th...

PRESENTED AT IAS 2021 – the 11th IAS Conference on HIV Science

PRESENTED AT IAS 2021 – the 11th IAS Conference on HIV Science

  • bency
  • 1 Slides

|18-21 JULY 2021. Weight gain in children and adol...

PROUD: Results and participant experiences

PROUD: Results and participant experiences

  • catherine
  • 17 Slides

Presented by . Mitzy. . Gafos. , behalf of the P...

Update from CROI 2023: Snippets from Seattle

Update from CROI 2023: Snippets from Seattle

  • scarlett
  • 28 Slides

Judith S. Currier, MD, MSc. Professor of Medicine....

Switch to DRV/r + 3TC DUAL Study

Switch to DRV/r + 3TC DUAL Study

  • jireh
  • 9 Slides

DRV/r 800/100 + 3TC 300 QD. N = 126. N = 123. DRV/...

When and What To Start Melanie A. Thompson, MD

When and What To Start Melanie A. Thompson, MD

  • paxton651
  • 14 Slides

Thacker & Thompson, MD. Atlanta, Georgia. Fina...

Prescribing PrEP in Title X Settings

Prescribing PrEP in Title X Settings

  • kaison
  • 25 Slides

Erika Aaron, CRNP. Disclosures. Successful Complet...

Switching From a Tenofovir

Switching From a Tenofovir

  • yael
  • 22 Slides

. Disoproxil. . Fumarate. (TDF)-Based Regimen to...

Copyright © 2024 DocSlides. All Rights Reserved